Navigate BioPharma Services, Inc. Launch Assay for Precise Measurement of Radioligand Therapy Response in Tumors
CARLSBAD, Calif., May 31, 2024 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, launch a new assay for quantifying pharmacodynamic markers of radioligand therapies in...
Sonny Meraban Scholarship for Entrepreneurs: Empowering the Innovators of Tomorrow
May 21, 2024, 11:37 ET
Sonny Meraban Scholarship for Entrepreneurs: Empowering the Innovators of Tomorrow
The Sonny Meraban Scholarship for Entrepreneurs proudly announces its call for applications, inviting undergraduate students from around the world to ...
Originally published at https://www.prnewswire.com/news-releases/sonny-meraban-scholarship-for-entrepreneurs-empowering-the-innovators-of-tomorrow-302151655.html
Images courtesy of...
Fannie Mae Announces the Results of its Thirty-first Reperforming Loan Sale Transaction USA – English USA – English
WASHINGTON, May 16, 2024 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) today announced the results of its thirty-first reperforming loan sale transaction. The deal, announced on April 16, 2024, included the sale of 6,484 loans totaling $1.47 billion in unpaid principal...
Consumer and Industry Advocates Outline Reforms to Property Tax Foreclosure Laws to Promote Sustainable Homeownership
WASHINGTON, May 30, 2024 /PRNewswire/ -- Across the nation, homeowners are losing their homes and the equity they've built due to unpaid property tax debts, and older adults, those on low or fixed incomes, and Black and Latino/Hispanic households are...
National Civil Rights Museum celebrates Juneteenth with free admission and a focus on health equity
Ford Philanthropy to sponsor free admission on the federal holiday Wednesday, June 19
Memphis, TN, June 05, 2024 (GLOBE NEWSWIRE) -- The National Civil Rights Museum is celebrating...
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
HAMILTON, ON and BOSTON, May 31, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced it has obtained a final order from the Ontario Superior Court of...